Infection of Rhesus Monkeys and Chimpanzees with Epstein-Barr Virus

Overview

Journal Arch Virol

Specialty Microbiology

Date 1980 Jan 1

PMID 6255902

Citations 10

Authors

P H Levine

S A LEISECA

J F Hewetson

K A Traul

A P Andrese

D J Granlund

P Fabrizio

D A Stevens

Affiliations

Soon will be listed here.

Abstract

Seventy-two nonhuman primates were entered into a long-term study to evaluate the pathogenicity of Epstein-Barr virus (EBV). Infectious virus was inoculated into 42 rhesus monkeys, 4 chimpanzees and 1 cynomolgus monkey. Immunostimulation or immunosuppression was attempted in 34 of these animals to enhance the oncogenic potential of the virus. Eleven inoculated animals were followed for more than 3 years and two were observed for 8 years. No tumors were observed in any of the animals; however, serological evaluation of the 47 inoculated primates and 25 matched controls indicated that at least 14 rhesus monkeys and the cynomolgus monkey were successfully infected with EBV. The potential use of rhesus monkeys as a model for EBV-induced disease in humans is discussed.

Citing Articles

Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants.

Evans T, Lowenstine L, Gilardi K, Barry P, Ssebide B, Kinani J Sci Rep. 2017; 7(1):5352.

PMID: 28706209 PMC: 5509654. DOI: 10.1038/s41598-017-04877-1.

Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Herrman M, Muhe J, Quink C, Wang F J Virol. 2015; 90(3):1222-30.

PMID: 26559839 PMC: 4719629. DOI: 10.1128/JVI.02531-15.

Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Jimenez S, Piera-Velazquez S Autoimmun Rev. 2013; 12(11):1046-51.

PMID: 23684698 PMC: 3771096. DOI: 10.1016/j.autrev.2013.04.004.

Simian herpesviruses and their risk to humans.

Estep R, Messaoudi I, Wong S Vaccine. 2010; 28 Suppl 2:B78-84.

PMID: 20510749 PMC: 2879342. DOI: 10.1016/j.vaccine.2009.11.026.

Simian TRIM5alpha proteins reduce replication of herpes simplex virus.

Reszka N, Zhou C, Song B, Sodroski J, Knipe D Virology. 2010; 398(2):243-50.

PMID: 20060996 PMC: 2823815. DOI: 10.1016/j.virol.2009.11.041.

References

Gerber P, Pritchett R, Kieff E . Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J Virol. 1976; 19(3):1090-9. PMC: 354949. DOI: 10.1128/JVI.19.3.1090-1099.1976. View

Hirshaut Y, Glade P, Vieira B, AINBENDER E, Dvorak B, SILTZBACH L . Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. N Engl J Med. 1970; 283(10):502-6. DOI: 10.1056/NEJM197009032831002. View

Levine P, OCONOR G, Bernard C . Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt's lymphoma. Cancer. 1972; 30(3):610-5. DOI: 10.1002/1097-0142(197209)30:3<610::aid-cncr2820300303>3.0.co;2-a. View

Henle G, Henle W . Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966; 91(3):1248-56. PMC: 316020. DOI: 10.1128/jb.91.3.1248-1256.1966. View

SIMONS M, Wee G, Chan S, Shanmugaratnam K . Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet. 1975; 1(7899):142-3. DOI: 10.1016/s0140-6736(75)91433-6. View

Deinhardt F, Falk L, Wolfe L, Paciga J, Johnson D . Response of marmosets to experimental infection with Epstein-Barr virus. IARC Sci Publ (1971). 1975; (11 Pt 2):161-8. View

Henle W, Henle G, Zajac B, Pearson G, Waubke R, Scriba M . Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970; 169(3941):188-90. DOI: 10.1126/science.169.3941.188. View

Levine P, Ablashi D, BERARD C, Carbone P, WAGGONER D, Malan L . Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer. 1971; 27(2):416-21. DOI: 10.1002/1097-0142(197102)27:2<416::aid-cncr2820270227>3.0.co;2-w. View

Miller G, Robinson J, Heston L . Immortalizing and nonimmortalizing laboratory strains of Epstein-Barr Virus. Cold Spring Harb Symp Quant Biol. 1975; 39 Pt 2:773-81. DOI: 10.1101/sqb.1974.039.01.089. View

10.

Reedman B, Klein G . Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973; 11(3):499-520. DOI: 10.1002/ijc.2910110302. View

11.

Gerber P, Birch S . Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1967; 58(2):478-84. PMC: 335660. DOI: 10.1073/pnas.58.2.478. View

12.

Shope T, DeChairo D, Miller G . Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A. 1973; 70(9):2487-91. PMC: 427039. DOI: 10.1073/pnas.70.9.2487. View

13.

Rabin H, Neubauer R, Pearson G, Cicmanec J, Wallen W, Loeb W . Spontaneous lymphoma associated with Herpesvirus saimiri in owl monkeys. J Natl Cancer Inst. 1975; 54(2):499-502. View

14.

Ziegler J, Magrath I, Gerber P, Levine P . Epstein-Barr virus and human malignancy. Ann Intern Med. 1977; 86(3):323-36. DOI: 10.7326/0003-4819-86-3-323. View

15.

Gazdar A, Russell E, Bassin R . In vivo enhancement of a murine sarcoma virus by diethylaminoethyl-dextran. Proc Soc Exp Biol Med. 1971; 137(1):310-4. DOI: 10.3181/00379727-137-35567. View

16.

Stevens D, Pry T, Blackham E, MANAKER R . Comparison of antigens from human and chimpanzee herpes-type virus-infected hemic cell lines. Proc Soc Exp Biol Med. 1970; 133(2):678-83. DOI: 10.3181/00379727-133-34543. View

17.

Epstein M, Hunt R, Rabin H . Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I Reticuloproliferative disease in an inoculated animal. Int J Cancer. 1973; 12(2):309-18. DOI: 10.1002/ijc.2910120202. View

18.

Gerber P, Branch J, Rosenblum E . Attempts to transmit infectious mononucleosis to rhesus monkeys and marmosets and to isolate herpes-like virus. Proc Soc Exp Biol Med. 1969; 130(1):14-9. DOI: 10.3181/00379727-130-33478. View

19.

Johansson B, Klein G, Henle W, Henle G . Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer. 1970; 6(3):450-62. DOI: 10.1002/ijc.2910060316. View

20.

Niederman J, McCOLLUM R, Henle G, Henle W . Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA. 1968; 203(3):205-9. DOI: 10.1001/jama.203.3.205. View